Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             302 results found
no title author magazine year volume issue page(s) type
1 ABCG2 variant rs2231142 in Parkinson’s disease Mai, P.-T.
2018
46 S2 p. e68
article
2 A case of progressive supranuclear palsy confused with alcohol-related dementia Maruta, J.
2018
46 S2 p. e92
article
3 A Chinese rapid-onset dystonia-parkinsonism case and literatures review Yang, J.
2018
46 S2 p. e55
article
4 A clinical cross-sectional study of Huntington’s Disease patients from China Liu, W.
2018
46 S2 p. e33
article
5 A comparison of cognition and toe tapping speed regulation ability in Parkinson’s disease patients: a pilot study Taniguchi, S.
2018
46 S2 p. e50
article
6 Actin polymerization dynamics are affected in spinocerebellar ataxia type 6 Liu, J.
2018
46 S2 p. e58
article
7 A curious case of restless legs syndrome masquerading as akathisia Tan, S.M.
2018
46 S2 p. e58
article
8 A dopamine-dependent activity in controlling the motor functions in cadmium induced neurotoxicity: Neuroprotective potential of quercetin Gupta, R.
2018
46 S2 p. e39
article
9 Alteration in dopaminergic neurotransmission following exposure to forced swim stress on the neurobehavioral toxicity of lambda-cyhalothrin in rats Shukla, R.K.
2018
46 S2 p. e42-e43
article
10 Analysis of GWAS-linked variants in multiple system atrophy Gu, X.
2018
46 S2 p. e30
article
11 A nationwide epidemiologic study of Parkinson’s disease in Korea using national health insurance database Lee, W.-W.
2018
46 S2 p. e75
article
12 A naturalistic observation on 20 consecutive patients under LCIG at the “Tor Vergata” University; enforced counseling and alternative route of LD delivery for avoiding discontinuation? Cerroni, R.E.
2018
46 S2 p. e22
article
13 Ancient Chinese description of Parkinson’s disease Le, W.
2018
46 S2 p. e66
article
14 An electrical muscle stimulation therapy for intractable tremor in Parkinson’s disease: a randomized sham-controlled trial of a tremor’s glove device Jitkritsadakul, O.
2018
46 S2 p. e26
article
15 An example for drug-disease interaction: Cardiac side effects related to rivastigmine in a patient with Lewy Body Dementia Celik, T.
2018
46 S2 p. e90
article
16 A novel MAPT mutation in a family of PSP look-alike phenotype Park, J.
2018
46 S2 p. e95
article
17 Antidepressants efficiency in patients with depression and depression related to Parkinson’s disease Kostyunina, A.
2018
46 S2 p. e49
article
18 Apathy in drug-naïve patients with Parkinson’s disease Liu, H.
2018
46 S2 p. e12
article
19 A potential therapeutic option for postural deformities in Parkinson disease Nose, K.
2018
46 S2 p. e86
article
20 A selective role of striatal dopamine in the timing of anticipatory postural adjustments at gait initiation in patients with Parkinson’s disease Palmisano, C.
2018
46 S2 p. e76-e77
article
21 Assessment of L-Dopa induced dyskinesia Tursunov, D.
2018
46 S2 p. e45
article
22 Assessment of the quality of life of patients with Parkinson’s disease with chronic pain syndrome Umarov, A.
2018
46 S2 p. e89
article
23 Assessment of the severity and progression of Parkinson’s disease Kim, Y.
2018
46 S2 p. e65
article
24 Association analysis of SNP rs11868035 in SREBF1 with Parkinson’s disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese population Yuan, X.
2018
46 S2 p. e30
article
25 Association between serum uric acid levels and disease severity in Parkinson patients To Thi Bich, P.
2018
46 S2 p. e11-e12
article
26 Association of SNCA in late-onset Parkinson’s disease with 22q11.2 deletion Vellingiri, B.
2018
46 S2 p. e71-e72
article
27 Author Index 2018
46 S2 p. e96-e102
article
28 Autonomic function tests in Parkinson’s disease and multiple system atrophy Vo Nguyen Ngoc, T.
2018
46 S2 p. e31
article
29 BDNF Val66Met polymorphism is associated with verbal memory dysfunction in Parkinson’s disease Hong, J.H.
2018
46 S2 p. e78-e79
article
30 Beneficial effect of laughter yoga and clapping exercise in Parkinson’s disease patients in south Delhi metro population Sharma, V.
2018
46 S2 p. e18-e19
article
31 Betaband event-related desynchronization prior to simple lower limb movement and simulated gait initiation in Parkinson’s disease patient: Magnetoencephalography study Yun, J.Y.
2018
46 S2 p. e77
article
32 17-beta-estradiol: A therapeutic potential drug for Parkinson’s disease Kumar, P.
2018
46 S2 p. e41
article
33 Bilateral globus pallidus internus deep brain stimulation for dystonic opisthotonus in atypical pantothenate kinase-associated neurodegeneration syndrome Mohd Fauzi, N.A.
2018
46 S2 p. e56-e57
article
34 Biochemical profile in patients with neurological Wilson’s disease Kumar, N.
2018
46 S2 p. e59-e60
article
35 Bioinformatics analysis of key genes and pathways in cellular model of Parkinson’s disease Lin, D.
2018
46 S2 p. e38
article
36 Body composition, sarcopenia and frailty in a multi-ethnic Asian cohort with Parkinson’s disease Tan, A.H.
2018
46 S2 p. e16-e17
article
37 Botulinum toxin: Central or peripheral mechanism of action? Lackovic, Z.
2018
46 S2 p. e3
article
38 Broad impairments of executive functions in Parkinson’s patients: a meta-analysis Chan, J.
2018
46 S2 p. e66
article
39 Can EMG help elucidate other possible cause of gait impairment in PD? Alvarez, M.
2018
46 S2 p. e64-e65
article
40 Cardinal symptoms of Parkinson’s disease cohabit with levodopa-induced dyskinesia Goubault, E.
2018
46 S2 p. e12
article
41 Carrier mediated delivery system bearing dopamine for effective management of Parkinsonism Bhargava, M.
2018
46 S2 p. e65
article
42 Case report: Chorea Gravidarum persisting after delivery Kamen, C.
2018
46 S2 p. e54
article
43 Case reports: Repetitive transcranial magnetic stimulation (rTMS) therapy for Parkinson’s disease (PD) Toyoda, C.
2018
46 S2 p. e88
article
44 11C-CFT-PET in presymptomatic FTDP-17: a potential biomarker predicting onset Liu, J.
2018
46 S2 p. e91
article
45 Cdnf Knockout mice show age-dependent changes in the function of dopaminergic terminals Panhelainen, A.
2018
46 S2 p. e39
article
46 Cervical dystonia: Clinical features of 50 cases in Vietnam Tran, T.
2018
46 S2 p. e34
article
47 Characteristic of cognitive disturbances in early stages of Parkinson disease Ruzimova, N.
2018
46 S2 p. e49-e50
article
48 Characteristics of neurocognitive disorders in patients with Parkinson’s disease in Vietnam Ny, T.T.H.
2018
46 S2 p. e69
article
49 Characterization and reproducibility of a macaque model of Parkinson’s disease alpha-synucleinopathy Koprich, J.
2018
46 S2 p. e3-e4
article
50 Chronic Mucuna pruriens in Parkinson’s disease: a non-inferiority, randomised, crossover, phase-2b trial Cilia, R.
2018
46 S2 p. e24
article
51 Clinical and cardiac autonomic profile of Parkinsonian and cerebellar phenotypes of probable multiple system atrophy Rukmani, M.R.
2018
46 S2 p. e28-e29
article
52 Clinical characteristics and quality of life in Chinese patients with multiple system atrophy Du, J.
2018
46 S2 p. e93
article
53 Clinical characteristics of young onset Parkinson’s disease Thai, H.
2018
46 S2 p. e73
article
54 Clinical features and differential diagnostic criteria of PANDAS syndrome and Sydenham’s chorea Nasirova, I.
2018
46 S2 p. e7
article
55 Clinical features and life quality in normosmic Parkinson’s Disease Cui, S.
2018
46 S2 p. e15
article
56 Clinical features associated with cognitive impairment in Chinese Parkinson’s disease patients: a cross-sectional study Du, J.
2018
46 S2 p. e48
article
57 Clinical profile of normal pressure hydrocephalous patients with suggested phenotypic variants Acharya, M.K.
2018
46 S2 p. e6-e7
article
58 Clinico-genetic correlation in Indian Spinocerebellar ataxia Type 1 (SCA1) patients Takkar, A.
2018
46 S2 p. e4
article
59 Cognitive impairment in Parkinson’s disease Narkulova, K.
2018
46 S2 p. e48
article
60 Cognitive impairment in Parkinson’s disease: Correlation with Apolipoprotein E genetic polymorphism and plasma a-synuclein Samat, N.A.
2018
46 S2 p. e28
article
61 Cognitive impairment in patients with Parkinson’s disease Manatova, R.
2018
46 S2 p. e71
article
62 Color vision impairment in Dementia with Lewy Bodies and prodromal Lewy bodies, a simple distinguishing feature from Alzheimer’s Dementia and prodromal Alzheimer’s disease Flanigan, P.
2018
46 S2 p. e29-e30
article
63 Combination of curcumin and ellagic acid mitigates rotenone induced locomotor, oxidative and mitochondrial deficits in mice Khatri, D.
2018
46 S2 p. e42
article
64 Committees 2018
46 S2 p. e2
article
65 Comorbid conditions associated with Parkinson’s disease: A population-based study from the Nebraska Parkinson’s Disease Registry Xu, K.
2018
46 S2 p. e15-e16
article
66 Comparative analysis of sleep disorders between groups of patients with Parkinson’s disease and Parkinson’s syndrome Djalilova, S.
2018
46 S2 p. e92
article
67 Comparison of gait parameters between drug-naive patients with multiple system atrophy with predominant Parkinsonism and Parkinson’s disease Na, B.S.
2018
46 S2 p. e31
article
68 Conflicts of western and eastern publications regarding spinocerebellar ataxias Turgunkhujaev, O.
2018
46 S2 p. e63
article
69 Cooperative synthesis of dopamine by striatal non-dopaminergic neurons as a mechanism of neuroplasticity at parkinsonism Kim, A.
2018
46 S2 p. e26-e27
article
70 C9ORF72 and frontotemporal dementia: a systematic review and meta- analysis Zhou, Q.
2018
46 S2 p. e51
article
71 Correlation analysis between cholinergic system and vegetative status in Parkinson disease Azizova, R.
2018
46 S2 p. e45
article
72 Co-segregating CACNA1A indel in pedigree with blepharospasm Tian, J.
2018
46 S2 p. e52
article
73 Could autophagy-related proteins be a biomarker in early Parkinson’s disease? Potential novel CSF biomarkers in Parkinson’s disease Jang, W.
2018
46 S2 p. e65
article
74 Could cardiac sympathetic denervation predict levodopa-induced dyskinesia in de novo Parkinson’s disease? Kang, S.-J.
2018
46 S2 p. e76
article
75 CSF Amyloid-β 40 and 42 are decreased in amyloid PET (-) normal pressure hydrocephalus Lim, T.S.
2018
46 S2 p. e60-e61
article
76 CSF biological markers of neurodegeneration in patients with Lewy body disease (LBD) and progressive supranuclear palsy (PSP) Frolova, M.
2018
46 S2 p. e31-e32
article
77 Current clinical views on Wilson’s disease Wang, X.-P.
2018
46 S2 p. e56
article
78 Deep brain stimulation: a more promising treatment’s indication in Parkinson’s disease dementia and Parkinson’s disease plus Alzheimer’s disease? Wang, X.-P.
2018
46 S2 p. e56
article
79 Deep brain stimulation therapy of levodopa-responsive motor fluctuations in patients with multiple system atrophy Hedera, P.
2018
46 S2 p. e91
article
80 Depression and bladder dysfunction in patients with Huntington’s disease Kolenc, M.
2018
46 S2 p. e55-e56
article
81 Depression and executive functions modulate motor-related brain activity in Parkinsonians Chan, J.
2018
46 S2 p. e8-e9
article
82 Depression in Parkinson’s disease: A case-control study Chang, M.-H.
2018
46 S2 p. e10
article
83 Depression in Parkinson’s disease: An initial study with the beck depression inventory Nguyenthanh, B.
2018
46 S2 p. e72
article
84 Depression in Parkinson’s disease: Relation with the level of “given up” activities Bogard, S.
2018
46 S2 p. e19
article
85 Design and evaluation of chitosan nanoparticles as novel drug carrier for the delivery of Galantamine to treat Alzheimer’s disease Jain, S.
2018
46 S2 p. e51
article
86 Detection, segmentation, and assessment of daily living activities using inertial sensor in people with Parkinson’s disease during a cleaning task Duval, C.
2018
46 S2 p. e83-e84
article
87 Development of nano-formulation containing rutin for the protective and beneficial effect against 6-hydroxydopamine induced Parkinson’s disease model via altered the genetic backgrounds Sahai, V.
2018
46 S2 p. e43
article
88 Diabetes mellitus accelerates the onset of levodopa-related motor complications and leads to lower MoCA scores in patients with mild to moderate Parkinsons disease Mohamed Ibrahim, N.
2018
46 S2 p. e67
article
89 Diagnostic accuracy of freezing index with wearable accelerometer for detecting freezing of gait in Parkinson’s disease Park, J.
2018
46 S2 p. e79
article
90 Diagnostic markers in the pathogenesis of parkinsonism syndrome development in chronic brain ischemia Khajibakiev, K.
2018
46 S2 p. e30-e31
article
91 Diagnostic value of striatal-prefrontal projection estimated by cerebral blood flow and dopamine transporter SPECT in Parkinsonian syndromes Nakano, Y.
2018
46 S2 p. e17
article
92 Dietary habits in Parkinson’s disease: adherence to Mediterranean diet Cassani, E.
2018
46 S2 p. e64
article
93 Differences in botulinum toxin treated and non-treated cervical dystonia patients in somatosensory task-related functional imaging response Nevrlý, M.
2018
46 S2 p. e37
article
94 Differential diagnosis of Parkinson’s Disease and multiple system atrophy Trufanov, Y.
2018
46 S2 p. e92
article
95 Differential gene expression analysis reveals pathway based functional association of dysregulated genes in Friedreich’s ataxia Singh, H.N.
2018
46 S2 p. e34
article
96 Discovery of novel pyrimidines as adenosine A2A receptor antagonist for benefit in Parkinson’s disease Singh, S.
2018
46 S2 p. e40
article
97 Discovery of 1,3,5-triazine-thiazoles (DDTR-502) as potent A2A antagonist/MAO-B inhibitor for the treatment of Parkinson’s disease Singh, U.P.
2018
46 S2 p. e39-e40
article
98 Do hypertension and calcium channel blocker agents increase the risk of Parkinson disease? Sanyasi, R.D.L.R.
2018
46 S2 p. e73
article
99 Dopamine dysregulation syndrome and deep brain stimulation in patients with Parkinson's disease Omarova, S.
2018
46 S2 p. e85
article
100 Dual neuroprotective role of Hsp2 against α-Synuclein aggregates Jamal, M.A.H.M.
2018
46 S2 p. e40
article
101 “Dynamic DAT” imaging is useful for diagnoses of parkinsonism with dementia Abe, K.
2018
46 S2 p. e81
article
102 Editorial Board 2018
46 S2 p. e1
article
103 Effect of diabetes mellitus on development of Parkinson's disease Kim, W.C.
2018
46 S2 p. e78
article
104 Effect of ropinirole alginate nanocomposite (RANC) on the transgenic Drosophila melanogaster model of Parkinson’s disease Naz, F.
2018
46 S2 p. e43
article
105 Effect of white matter hyperintensities on non-motor symptoms in Parkinson’s disease Kim, J.S.
2018
46 S2 p. e70
article
106 Effects of an aerobic exercise on the recovery of forelimb function in 6-OHDA rat-model of Parkinson’s disease Ohno, Y.
2018
46 S2 p. e42
article
107 Effects of once-daily valbenazine on Tardive Dyskinesia by body region Siegert, S.
2018
46 S2 p. e27
article
108 Efficacy and safety of Valbenazine (NBI-98854) in subjects with tardive dyskinesia: Results of a long-term study (KINECT 3 extension) Siegert, S.
2018
46 S2 p. e35
article
109 Efficacy of rasagiline and selegiline in Parkinson’s disease: A head-to-head 3-year retrospective case-control study Cereda, E.
2018
46 S2 p. e18
article
110 Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in subjects with Parkinson’s disease: preliminary results from the Phase-3 study dose-titration phase Espay, A.J.
2018
46 S2 p. e19
article
111 Electric stimulation evoked potential of subthalamic nucleus in deep brain stimulation surgery: a preliminary study Lin, S.-H.
2018
46 S2 p. e86
article
112 Epidemiology of Parkinson’s disease in Africa: Challenges and opportunities Gams Massi, D.
2018
46 S2 p. e10
article
113 Evaluation of serum amino acid levels in patients with Parkinson’s Disease Figura, M.
2018
46 S2 p. e75
article
114 Evaluation of serum hepcidin concentrations in Parkinson’s disease patients Manolov, V.
2018
46 S2 p. e74-e75
article
115 Evaluation of the relationship between cigarette smoking with risk of essential tremor in Singapore population Setiawan, F.
2018
46 S2 p. e34
article
116 Evaluation of the therapeutic potential of Tangeritin against the symptoms of Parkinson’s disease Fatima, A.
2018
46 S2 p. e43
article
117 Evaluation of various movement disorders in patients of genetically proven Spino Cerebellar Ataxia: A study from a tertiary care center in Northern India Madathiparambil Radhakrishnan, D.
2018
46 S2 p. e23
article
118 Evaluations of additive effect of two Indigenous medicinal plants Cedrus deodara and Mucuna pruriens towards the treatment of Parkinsons disease Jain, S.
2018
46 S2 p. e87
article
119 Excellent outcome after bilateral pallidal deep brain stimulation in generalized dystonia due to amphetamine-induced bilateral basal ganglia necrosis Suengtaworn, A.
2018
46 S2 p. e52-e53
article
120 Excessive daytime sleepiness decreases the quality of life and daytime activity in Parkinson’s disease Babkina, O.
2018
46 S2 p. e69
article
121 Executive dysfunction, behavioral changes and quality of life in Chinese patients with progressive supranuclear palsy Ou, R.
2018
46 S2 p. e91
article
122 Facio-oculo-palatal myoclonus complicated by recurrent brainstem infarction Pitakpatapee, Y.
2018
46 S2 p. e58-e59
article
123 Falls in patients with Parkinson’s disease (PD) and their association with bone mineral density (BMD) Khoo, C.S.
2018
46 S2 p. e76
article
124 Features of cognitive functions of Parkinson’s disease (PD) and vascular parkinsonism Tolibov, D.
2018
46 S2 p. e62
article
125 Features of MRI signs of Parkinson’s disease (PD) and vascular parkinsonism Umarov, A.
2018
46 S2 p. e62-e63
article
126 Features of P300 cognitive potentials in Parkinson’s disease Ruzimurodov, N.
2018
46 S2 p. e80
article
127 Frailty and cognitive impairment Yoon, S.J.
2018
46 S2 p. e47
article
128 Gender-age features of autonomic heart rhythm disturbances in Parkinson’s disease patients Solodovnikova, Y.
2018
46 S2 p. e80
article
129 Glucocerebrocidase gene variants in Malays with Parkinson’s disease Mohamad Pakarul Razy, N.F.
2018
46 S2 p. e74
article
130 Glucocerebrosidase gene mutation in Parkinson’s disease Macas, M.
2018
46 S2 p. e15
article
131 Gnal haploinsufficiency causes genomic instability and increased sensitivity to haloperidol Khan, M.M.
2018
46 S2 p. e46
article
132 Greater motor progression in patients with Parkinson disease who carry PARK 16 variant Deng, X.
2018
46 S2 p. e14
article
133 Heat shock Drosophila serine protease-2 mediated detoxification of α-Synuclein induced neurotoxicity in a Drosophila model of Parkinson’s disease Islam, M.S.
2018
46 S2 p. e69
article
134 Hemidystonia in a 28-year old CLCN2 homozygous Filipino female Torres, J.A.K.
2018
46 S2 p. e55
article
135 Hormonal pathogenetic effects and vascular-immunological aspects in secondary vascular parkinsonism Akramova, D.
2018
46 S2 p. e61
article
136 Identification imprinting gene expression at 15q11-q13 region in Angelman syndrome Vijayakumar, P.
2018
46 S2 p. e53-e54
article
137 Identification of a novel locus in a large pedigree with Parkinson’s disease Monfrini, E.
2018
46 S2 p. e72-e73
article
138 Identification of MicroRNAs and their target genes modulating Spinocerebellar Ataxia type-2 (SCA2) pathogenesis Swarup, V.
2018
46 S2 p. e5-e6
article
139 Impact of frontal lobe function and behavioral changes on quality of life in patients with multiple system atrophy Zhang, L.
2018
46 S2 p. e30
article
140 Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson’s disease Kim, J.
2018
46 S2 p. e15
article
141 Impaired freeze response in psychogenic (functional) movement disorder patients during exposure to stress Zito, G.A.
2018
46 S2 p. e23-e24
article
142 Implementation of cloud technologies for prediction of morbidity from Parkinson’s disease and optimization of medical resources Ishmatova, S.
2018
46 S2 p. e80
article
143 Impulse control disorder frequency in different parkinsonism syndromes Bayram, E.
2018
46 S2 p. e29
article
144 Increased free locomotor activity in rats after intraperitoneal injection of 1-Methylxanthine versus caffeine: a comparative study Jimenez-Botello, L.C.
2018
46 S2 p. e46
article
145 Influence of medial temporal lobe atrophy on the progress of cognitive impairment in patient with dementia with Lewy bodies Matsuda, Y.
2018
46 S2 p. e90
article
146 Influence of physical training on executive functions in Parkinson’s disease Slotwinski, K.
2018
46 S2 p. e47
article
147 Interrelation of cognitive impairments and quality of life between motor disorders in patients with vascular Parkinsonism Tolibov, D.
2018
46 S2 p. e62
article
148 Interrelationships between survival, sex and blood pressure in patients with multiple system atrophy Gurevich, T.
2018
46 S2 p. e31
article
149 Investigation of LRRK2 variant and essential tremor Ratnagopal, P.
2018
46 S2 p. e67
article
150 Investigation to expand application sites of rotigotine transdermal patch Kujirai, H.
2018
46 S2 p. e84
article
151 In vivo direct conversion of adult astrocytes to dopaminergic neurons using ALN polycistronic vector Kim, Y.E.
2018
46 S2 p. e45
article
152 levodopa-induced motor complications in Vietnamese patients with Parkinson’s disease Dang, T.H.T.
2018
46 S2 p. e70
article
153 Localization of dystonic muscles with positron emission tomography/computed tomography for the treatment of cervical dystonia Shen, Y.
2018
46 S2 p. e56
article
154 Long-duration response to Levodopa in advanced Parkinson’s disease: relevance for RCT on disease-modifying therapies Cilia, R.
2018
46 S2 p. e82
article
155 Long-term efficacy of inhaled levodopa in Parkinson’s disease subjects with motor fluctuations: Interim results of a phase 3 study Grosset, D.
2018
46 S2 p. e19
article
156 Long-term pulmonary safety of inhaled levodopa in parkinson’s disease subjects with motor fluctuations: interim results of a phase 3 study Grosset, D.
2018
46 S2 p. e83
article
157 Long term result and safety of the subthalamic nucleir dbs of advanced parkinson’s disease: an eight years follow up study Guo, Q.
2018
46 S2 p. e86
article
158 Long term results of the VANTAGE study: A prospective multicenter trial evaluating deep brain stimulation with a multiple source, constant current system in Parkinson’s disease Brücke, T.
2018
46 S2 p. e25
article
159 LRRK2 GTPase domain variants in Dementia Zhang, X.J.
2018
46 S2 p. e28
article
160 LRRK2 variant is associated with lower risk of essential tremor Ng, S.H.
2018
46 S2 p. e9
article
161 Microarray analysis of an in vitro model induced by an α-synuclein oligomer reveals the expression profile of long non-coding RNA in Parkinson‘s disease Tao, E.
2018
46 S2 p. e38
article
162 MicroRNA-4639 is a regulator of DJ-1 expression and a potential diagnostic marker for early Parkinson’s disease Chen, Y.
2018
46 S2 p. e24
article
163 microRNAs in plasma as biomarkers for Parkinson’s disease Le, W.
2018
46 S2 p. e66
article
164 Mobility in people with Parkinson’s disease with different medication profile Faucher, G.
2018
46 S2 p. e83
article
165 Modifiers of age at onset in spinocerebellar ataxia type 2(SCA2): CAG length of other SCA loci do not influence age at onset in SCA2 Singh, R.
2018
46 S2 p. e61-e62
article
166 Molecular mechanisms of neurodegeneration and neuroplasticity in the nigrostriatal system at modeling Parkinson’s disease as an instrument for translational medicine Mingazov, E.
2018
46 S2 p. e43-e44
article
167 Motor and cognitive impairment in patients with Parkinson’s disease who underwent ischemic stroke Mukhamedkhanova, M.
2018
46 S2 p. e77-e78
article
168 Motor-symptom laterality affects acquisition in Parkinson’s disease: A cognitive and functional magnetic resonance imaging study Huang, P.
2018
46 S2 p. e10
article
169 Movement disorders in patients with Japanese encephalitis: Experience in a tertiary care hospital in North Eastern region of India Barua, A.R.
2018
46 S2 p. e4
article
170 Multi-center observational study of personality and impulse control disorders in Japanese patients with Parkinson’s disease Shinoda, T.
2018
46 S2 p. e68
article
171 Mutational analysis of Parkin gene in early-onset of Parkinson’s disease of Coimbatore population Venkatesan, D.
2018
46 S2 p. e67
article
172 Neuromodulation by rTMS in Parkinsons disease Goyal, V.
2018
46 S2 p. e88
article
173 Neuromodulation of NBIA-related dystonia Kmiec, T.
2018
46 S2 p. e36-e37
article
174 Neuroprotective effect of rutin on iron induced oxidative stress and cytotoxicity in PC12 neuronal cells via Bcl-2/Bax/caspase-3 signaling pathways Rahman, M.
2018
46 S2 p. e38-e39
article
175 Neuropsychiatric disorders in idiopathic Parkinson’s disease Halder, S.
2018
46 S2 p. e48-e49
article
176 Neuropsychiatric symptoms impact on quality life of patients with Parkinson’s disease Sultonova, D.
2018
46 S2 p. e49
article
177 New insight in the screening of tandem repeats among spinocerebellar ataxia patients Suroliya, V.
2018
46 S2 p. e62
article
178 Non-motor predictors of early manifestations of Parkinson’s disease Azizova, R.
2018
46 S2 p. e79
article
179 Non-motor symptoms in patients with autosomal dominant spinocerebellar ataxia Kamble, N.
2018
46 S2 p. e5
article
180 Novel paradigm for the development of preclinical diagnosis of Parkinson’s disease based on searching blood markers and a provocation test Ugrumov, M.
2018
46 S2 p. e44
article
181 Novel POLG mutation in a patient with early-onset parkinsonism, progressive external ophthalmoplegia and optic atrophy Ma, L.
2018
46 S2 p. e29
article
182 Nurr1 deficiency-mediated inflammatory injury to nigral dopamine neurons in Parkinson’s disease Dong, J.
2018
46 S2 p. e66
article
183 Objective versus subjective assessments of freezing of gait: An observational study of patients with Parkinson’s disease and related disorders in Singapore Nicole Chia, S.Y.
2018
46 S2 p. e13
article
184 Occipital hypometabolism on [18F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder is less prominent than those of patients with Parkinson’s disease Kashihara, K.
2018
46 S2 p. e72
article
185 Ocular motor disorders among X-linked Dystonia Parkinsonism (XDP) patients Macas, M.
2018
46 S2 p. e33-e34
article
186 Oral health of Parkinson’s disease patients, a case-control study de Baat, C.
2018
46 S2 p. e13
article
187 Oxotremorine model of tremor Tursunov, D.
2018
46 S2 p. e45
article
188 Pain in Parkinson disease: a local single-center correlational study of ambulatory Parkinson disease patients Sy, M.A.C.
2018
46 S2 p. e17
article
189 Paradoxical worsening of parkinsonism upon neuroleptic withdrawal: More common than we think? Florescu, A.
2018
46 S2 p. e59
article
190 Parkinson disease therapy during Ramadhan fasting month. A case report Abdul Halim, S.
2018
46 S2 p. e85-e86
article
191 Parkinsonian syndrom prevalence in the world Akmal, I.
2018
46 S2 p. e46
article
192 Parkinsonism in manganese-exposed welder: Case report Gultekin, M.
2018
46 S2 p. e60
article
193 Parkinson’s disease among combat veterans exposed to hazardous chemicals Siddharthan, K.
2018
46 S2 p. e64
article
194 Patient-related factors’ impact on caregiver burden in Parkinson’s disease in Singapore Lim, E.C.
2018
46 S2 p. e81
article
195 Patients and their caregivers’ burdens for Parkinson’s disease in Korea Baik, J.S.
2018
46 S2 p. e14
article
196 Patterns of neuropsychological profiles according to severity of depressive symptoms in newly diagnosed Parkinson’s disease patients Kim, S.J.
2018
46 S2 p. e67
article
197 Peripheral distribution of α - synuclein pathology: A case of Parkinson‘s disease Jang, M.
2018
46 S2 p. e72
article
198 Phenotypic differences in genetically characterized Spinocerebellar Ataxia Type 2(SCA2): A largest case series from India Sonakar, A.K.
2018
46 S2 p. e7
article
199 Physical activity and its impact on non-motor aspects of Parkinson’s disease - the Early Parkinson’s Disease Longitudinal Singapore (PALS) study Samuel Ng, Y.E.
2018
46 S2 p. e18
article
200 Pooled analysis of phase 3 studies of ADS-5102 for levodopa-induced dyskinesia: A detailed review of MDS-UPDRS, part IV (motor complications) Tanner, C.
2018
46 S2 p. e20
article
201 Positional asphyxia, the rare but fatal complication of nocturnal hypokinesia: A case report Sringean, J.
2018
46 S2 p. e80-e81
article
202 Postural instability in ambulatory Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA); possible different mechanism from Parkinson’s disease Panyakaew, P.
2018
46 S2 p. e93
article
203 Predictors of further freezing of gait in Parkinson’s disease: a prospective study from southwest of China Ou, R.
2018
46 S2 p. e65-e66
article
204 Preliminary evidence of functional compensation in premanifest Huntington’s disease using a novel visuospatial working memory task Soloveva, M.
2018
46 S2 p. e37
article
205 Prevalence of and indications for antipsychotic use in Parkinson disease Bower, J.
2018
46 S2 p. e88-e89
article
206 Prevalence of Axis-1 DSM-4 psychiatric disorders in patients with parkinsonism using a structured interview(MINI) in a rural-based neurology clinic in India Singh, S.
2018
46 S2 p. e70-e71
article
207 Prevalence of cerebral and cardiovascular disease in Parkinson’s disease patients: A meta-analysis Hong, C.T.
2018
46 S2 p. e9
article
208 Prevalence of hemochromatosis (HFE) gene mutations in Friedreich’s Ataxia patients and peripheral neuropathy Singh, I.
2018
46 S2 p. e4
article
209 Prevalence of Parkinson disease in the city of South Delhi, India Shahi, A.
2018
46 S2 p. e79
article
210 Prevalence of Parkinson’s disease and drug-induced Parkinsonism from National Health Insurance Service Claims Data (NHISCD) Ma, H.-I.
2018
46 S2 p. e6
article
211 Prevalence of Parkinson’s disease in Bihar, India Kumar, G.
2018
46 S2 p. e71
article
212 Primary progressive freezing gait with bilateral basal ganglia lesion in a uremic patient Kim, S.J.
2018
46 S2 p. e58
article
213 Psychotherapeutic treatment of cognitive impairtment in children with tic hyperkinesis Sattarova, D.
2018
46 S2 p. e49
article
214 Purinergic receptor P2Y6 contribute to 1-methyl-4-phenylpyridinium- induced oxidative stress and cell death in neuronal SH-SY5Y cell Qian, Y.
2018
46 S2 p. e38
article
215 Putaminal dopamine depletion patterns in de novo Parkinson’s disease predicts later development of motor complication types Sohn, Y.H.
2018
46 S2 p. e10-e11
article
216 Quality of life in patients with Parkinson’s disease Kamenova, S.
2018
46 S2 p. e68-e69
article
217 Rapid eye movement behavior disorder in drug-naïve patients with Parkinson’s disease Liu, H.
2018
46 S2 p. e14
article
218 Rapid eye movement sleep behavior disorder and predominant non-motor symptoms subtypes in Chinese Parkinson’s disease patients: a questionnaire-based study Wu, Y.
2018
46 S2 p. e77
article
219 Rare GCH1 heterozygous variants contributing to Parkinson’s disease Guo, J.
2018
46 S2 p. e13-e14
article
220 Recommendation for modeling of parkinsonian syndrome Safarbekov, D.
2018
46 S2 p. e44-e45
article
221 Reduced arm swing during gait in patients with Parkinson disease: Objective motion analysis study Park, Y.M.
2018
46 S2 p. e16
article
222 Rehabilitation program with or without a muscle-targeted nutritional support in patients with Parkinson’s disease or parkinsonism: study design of a randomized, controlled trial Barichella, M.
2018
46 S2 p. e89
article
223 Rehabilitative experience with motor imagery in progressive supranuclear palsy - A case report Kaur, D.
2018
46 S2 p. e84
article
224 Relationship between predominant non-motor subtypes and motor fluctuations in Parkinson’s disease: a cohort study from southwest of China Wu, Y.
2018
46 S2 p. e78
article
225 Reprogramming in inflammatory response to neuronal damage induced by the brain LPS preconditioning: Possible implications in rat model of Parkinson’s disease Golpich, M.
2018
46 S2 p. e3
article
226 Resting-state fMRI study on drug-naive Parkinson’s disease patients with hyposmia Shushan, Z.
2018
46 S2 p. e76
article
227 Resting-state network connectivity in cognitively unimpaired drug-naïve patients with rigidity-dominant Parkinson’s disease Hou, Y.
2018
46 S2 p. e75-e76
article
228 Results from a phase 1b multiple ascending-dose study of PRX002/RG7935, an Anti-alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease Jankovic, J.
2018
46 S2 p. e25
article
229 Rho kinase inhibitors - A growing neuroprotective therapeutic paradigm Abbhi, V.
2018
46 S2 p. e48
article
230 Rifampicin suppresses inflammation via modulation of autophagy in rotenone-induced microglia Liang, Y.
2018
46 S2 p. e40
article
231 Risk factors of developing Parkinson’s disease Turaeva, G.
2018
46 S2 p. e41
article
232 Role of anticholinergic medications in the treatment of Parkinson’s disease Mishima, T.
2018
46 S2 p. e85
article
233 Rotenone model of Parkinson’s syndrome Kodirova, D.
2018
46 S2 p. e41-e42
article
234 Safety and efficacy of DaxibotulinumtoxinA for injection (RT002) in cervical dystonia (CD): Results of a phase 2, dose escalating study Truong, D.
2018
46 S2 p. e27
article
235 Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF-episodes in subjects with Parkinson’s disease: preliminary results from the Phase-3 study dose titration phase Fernandez, H.H.
2018
46 S2 p. e82
article
236 Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06649751, an oral Dopamine D1/D5 agonist, in Parkinson’s disease: A single ascending dose study Gray, D.
2018
46 S2 p. e20
article
237 Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral Dopamine D1/D5 agonist PF-06649751 in Parkinson’s disease: A multiple ascending dose study Gray, D.
2018
46 S2 p. e20-e21
article
238 Screening for TMEM230 mutations in young onset Parkinson’s disease Ma, D.
2018
46 S2 p. e70
article
239 Screening of ApoE genotypic frequency and analysis of neurotransmitter levels in Alzheimer’s patients of Coimbatore population Venugopal, A.
2018
46 S2 p. e47
article
240 Shaky and unsteady: Dynamic posturography in essential tremor Prasad, S.
2018
46 S2 p. e33
article
241 Short-term memory defects and emotional changes following sleep deprivation in a rotenone treated Zebrafish model of Parkinson disease Lv, D.
2018
46 S2 p. e44
article
242 Sleep disturbances and quality of life in people with Parkinson’s disease Chotphoksap, U.
2018
46 S2 p. e73-e74
article
243 Some movement disorders as diagnostic predictions of Juvenile chorea Sanoyeva, M.
2018
46 S2 p. e52
article
244 Start react paradigm in patients with cervical dystonia Singh, R.
2018
46 S2 p. e55
article
245 STN DBS can temporarily improve balance disorders in Parkinson’s disease patients Szlufik, S.
2018
46 S2 p. e88
article
246 Stop signal reaction time in Cervical Dystonia and Parkinson’s patients Roy, A.
2018
46 S2 p. e35-e36
article
247 Stress response of autonomic nervous system during conditioned inhalation general anesthesia for deep brain stimulation Chen, S.Y.
2018
46 S2 p. e86-e87
article
248 Study of the role of vitamin D and insulin resistance in patients with Parkinson’s disease Bajenaru, O.-L.
2018
46 S2 p. e71
article
249 Survival analysis and prognostic nomogram in multiple system atrophy Cao, B.
2018
46 S2 p. e93
article
250 Synchronicity of climate fluctuation with daily activity of alpha synucleinopathic patients Turgunkhujaev, O.
2018
46 S2 p. e90
article
251 Taking the step towards predicting Parkinson’s disease Chimagomedova, A.
2018
46 S2 p. e77
article
252 Tele-health for patients with deep brain stimulation: A retrospective chart review Jitkritsadakul, O.
2018
46 S2 p. e84
article
253 Tetrahydroisoquinoline molecule of Indian ayurveda medicine: Therapeutic potential in Parkinson’s disease Banerjee, R.
2018
46 S2 p. e85
article
254 The association between early treatment with amantadine and delayed onset of levodopa-induced dyskinesia in patients with Parkinson’s disease Wu, T.L.
2018
46 S2 p. e14-e15
article
255 The association of perceived stress and the frequency and severity of non-motor symptoms in Parkinson’s disease Cusso, M.
2018
46 S2 p. e12
article
256 The availability of anti-Parkinsonian drugs in Thailand and associated factors Sakdisornchai, K.
2018
46 S2 p. e21
article
257 The clinical feature of stroke related restless legs syndrome Zhang, X.J.
2018
46 S2 p. e60
article
258 The effectiveness of neurometabolic treatment of Parkinson’s disease (PD) and vascular parkinsonism Ruzimurodov, N.
2018
46 S2 p. e87
article
259 The effect of apolipoprotein E ε4 (APOE ε4) on visuospatial working memory in healthy elders and amnestic mild cognitive impairment patients: an event-related potentials study Gu, L.
2018
46 S2 p. e50-e51
article
260 The effect of levodopa treatment on endothelial function in patients with Parkinson’s disease: Serial flow-mediated dilation studies Yoon, J.
2018
46 S2 p. e84-e85
article
261 The effect of the Nordic Walking on motor functions in Parkinson’s disease Stożek, J.
2018
46 S2 p. e87
article
262 The findings of dysphagia in patients with Parkinson’s disease, using videofluoroscopic study Lim, S.H.
2018
46 S2 p. e8
article
263 The first case report of neuroacanthocytosis in Vietnam Vo Nguyen Ngoc, T.
2018
46 S2 p. e54
article
264 The frequency of motor disorders in diabetic encephalopathy Gumarova, A.
2018
46 S2 p. e59
article
265 The identification of molecular-genetic background of familial atypical parkinsonism in “Hornacko”, a specific region of the South-Eastern Moravia, Czech Republic Mensikova, K.
2018
46 S2 p. e90-e91
article
266 The impact of Apolipoprotein E gene polymorphism on the cerebral blood flow in patients with mild cognitive impairment Zhu, L.
2018
46 S2 p. e51
article
267 The impact of levodopa-induced complications on the quality of life of patients with Parkinson’s disease Manharlal, P.K.
2018
46 S2 p. e69-e70
article
268 The importance of apoproteins in the development of Parkinson’s disease Dilzoda, A.
2018
46 S2 p. e42
article
269 The influence of smell and taste disturbances on the nutritional status in Parkinson disease Koszewicz, M.
2018
46 S2 p. e20
article
270 The involvement of dopamine in pain modulation in the nucleus accumbens of 6-OHDA induced parkinson’s disease rat model Zhang, X.-Q.
2018
46 S2 p. e40-e41
article
271 The modifying effect of age on survival in Parkinson’s disease: Big data analysis Peretz, C.
2018
46 S2 p. e11
article
272 The MRI-based brain structure measurements in Parkinson’s disease and Parkinson-plus syndromes Peng, S.
2018
46 S2 p. e91-e92
article
273 The mutual relationship of bilateral subthalamic stimulation initial impact on the non-motor and motor symptoms in Parkinson’s disease - an open prospective study Kurcova, S.
2018
46 S2 p. e82-e83
article
274 The pathogenesis of vascular parkinsonism Makhkamova, M.
2018
46 S2 p. e60
article
275 Therapeutic effect of non-invasive vagus nerve stimulation in gait disturbance and freezing in Parkinson’s disease patients Mondal, B.
2018
46 S2 p. e21
article
276 The role of botulinum toxin on pain and gait impairment in cervical dystonia Chatterjee, K.
2018
46 S2 p. e54-e55
article
277 The role of the endothelial growth factor (EGF) in Parkinson disease Fakhargalieva, S.
2018
46 S2 p. e79-e80
article
278 The therapeutic effect of MANF in the MPTP/MPP+-induced model of Parkinson’s disease Liu, Y.
2018
46 S2 p. e39
article
279 The usefulness of skin fold thickness measurements in the estimation of the nutritional status in Parkinson disease Budrewicz, S.
2018
46 S2 p. e73
article
280 To study the genotype - phenotype correlation of Friedreich’s Ataxia (FRDA) patients in Indian population Ahmad, I.
2018
46 S2 p. e7
article
281 Treadmill training lessens dopaminergic deficiency, enhances BDNF and GDNF biosynthesis, and reduces brain inflammation in the MPTP mouse model of Parkinson’s disease Palasz, E.
2018
46 S2 p. e41
article
282 Tremor in spinocerebellar ataxia type12 (SCA-12) mimics essential tremor (ET) Narang, M.K.
2018
46 S2 p. e36
article
283 Turn cranio-caudal signature assessment from inertial systems for mobility deficit identification in Parkinson’s disease patients Lebel, K.
2018
46 S2 p. e24-e25
article
284 Twofold load of tandem repeat expansion and their impact on ADCA patients Shakya, S.
2018
46 S2 p. e61
article
285 Two new mutations of CP gene associated with Aceruloplasminemia and basal ganglia cavitation Riboldi, G.M.
2018
46 S2 p. e63
article
286 UPDRS III and reflexive saccades latency indicate that STN DBS has therapeutic neuromodulatory effects in Parkinson’s disease Szlufik, S.
2018
46 S2 p. e87-e88
article
287 Validation of the Korean version of the composite autonomic symptom scale-31 (COMPASS-31) Kim, Y.
2018
46 S2 p. e93-e94
article
288 Validity and reliability study of Indonesian version of scales for outcomes in Parkinson’s Disease-Sleep (SCOPA-SLEEP INA) Astiny, D.
2018
46 S2 p. e74
article
289 Validity of the 5-item clock-drawing scoring system in screening of dementia in Parkinson’s disease patients Tangkanakul, C.
2018
46 S2 p. e8
article
290 Value of intraoperative neurophysiological monitoring for clinical outcome of deep brain stimulation of subthalamic nucleus in Parkinson’s disease Gamaleya, A.
2018
46 S2 p. e22
article
291 Variants in MCCC1/LAMP3 and DGKQ identified through GWAS are not associated with PD in a Malaysian Malay cohort Lim, J.L.
2018
46 S2 p. e11
article
292 Video amplification as a sensitive screening tool for orthostatic tremor Shou, J.
2018
46 S2 p. e27
article
293 Visual spatial dysfunction and retinal nerve fiber layer thickness in patients with Parkinson Disease Teh, P.C.
2018
46 S2 p. e24
article
294 Visuospatial dysfunction in cube copying test and clock drawing test in non-demented Parkinson’s disease: a volumetric analysis Ahn, T.-B.
2018
46 S2 p. e50
article
295 Volumetric magnetic resonance imaging differences in essential tremor compared to Parkinson’s disease Franco, G.
2018
46 S2 p. e36
article
296 Voxel-based meta-analysis of gray and white matter volume reductions in spinocerebellar ataxia type 2 Han, Q.
2018
46 S2 p. e4-e5
article
297 ‘Walking on a bamboo stick’: A self-invented tactile cue for freezing of gait in a patient with Parkinson’s disease Rattanachaisit, W.
2018
46 S2 p. e94
article
298 When movement disorders hurt: Addressing pain in hyperkinetic disorders Relja, M.
2018
46 S2 p. e54
article
299 White matter alterations in Parkinson’s disease with normal cognition precede grey matter atrophy Rektor, I.
2018
46 S2 p. e9-e10
article
300 White matter hyperintensity and dementia conversion in Parkinson’s disease Cheon, S.-M.
2018
46 S2 p. e68
article
301 Writer’s Cramp: Brainstem connection revisited Choudhury, S.
2018
46 S2 p. e36
article
302 Zonisamide improves Parkinsonism in Dementia with Lewy Bodies (DLB): A randomized double-blind placebo-controlled Phase 3 study Hasegawa, K.
2018
46 S2 p. e26
article
                             302 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands